?>
Plan Name | AMERICAN COLLEGE OF RHEUMATOLOGY WORKSITE PLAN |
Plan identification number | 503 |
401k Plan Type | Welfare Benefit |
Plan Features/Benefits |
|
Company Name: | AMERICAN COLLEGE OF RHEUMATOLOGY |
Employer identification number (EIN): | 581627547 |
NAIC Classification: | 813000 |
NAIC Description: | Religious, Grantmaking, Civic, Professional, and Similar Organizations |
Additional information about AMERICAN COLLEGE OF RHEUMATOLOGY
Jurisdiction of Incorporation: | Texas Secretary of State |
Incorporation Date: | 2018-07-06 |
Company Identification Number: | 0803060566 |
Legal Registered Office Address: |
2200 LAKE BLVD NE BROOKHAVEN United States of America (USA) 30319 |
More information about AMERICAN COLLEGE OF RHEUMATOLOGY
Plan id# | Filing Submission Date | Name of Administrator | Date Administrator Signed | Name of Company Sponsor | Date Sponsor Signed |
---|---|---|---|---|---|
503 | 2022-06-01 | STEVEN ECHARD | 2023-11-30 |
Measure | Date | Value |
---|---|---|
2022: AMERICAN COLLEGE OF RHEUMATOLOGY WORKSITE PLAN 2022 401k membership | ||
Total participants, beginning-of-year | 2022-06-01 | 100 |
Total number of active participants reported on line 7a of the Form 5500 | 2022-06-01 | 123 |
Number of retired or separated participants receiving benefits | 2022-06-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2022-06-01 | 0 |
Total of all active and inactive participants | 2022-06-01 | 123 |
Number of employers contributing to the scheme | 2022-06-01 | 0 |
2022: AMERICAN COLLEGE OF RHEUMATOLOGY WORKSITE PLAN 2022 form 5500 responses | ||
---|---|---|
2022-06-01 | Type of plan entity | Single employer plan |
2022-06-01 | First time form 5500 has been submitted | Yes |
2022-06-01 | Plan funding arrangement – Insurance | Yes |
2022-06-01 | Plan benefit arrangement – Insurance | Yes |
PAUL REVERE VARIABLE ANNUITY INS. CO. (National Association of Insurance Commissioners NAIC id number: 67601 ) | |||||||||||||||||||||||||||
Policy contract number | 714587 | ||||||||||||||||||||||||||
Policy instance | 1 | ||||||||||||||||||||||||||
|